Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

Biden admin questioned over abortion pill push without proper environmental study

by May 29, 2024
May 29, 2024
Biden admin questioned over abortion pill push without proper environmental study

: Bicameral lawmakers are highlighting the Biden administration’s failure to adequately study the environmental impact of the abortion pill, particularly amid the rise in at-home medication abortions. 

‘The full impact of mifepristone has never been sufficiently studied,’ Sen. Marco Rubio, R-Fla., and Rep. Josh Brecheen, R-Okla., wrote in a letter to Michael Regan, President Biden’s Environmental Protection Agency (EPA) administrator.

The lawmakers stressed the importance of this development in light of the rising number of medication-induced abortions, for which mifepristone is commonly administered. According to the Guttmacher Institute, 63% of all U.S. abortions last year were conducted by medication. This marked a 10% rise in the method relative to the share of all abortions since 2020. 

Rubio and Brecheen alleged that the only survey of the effect mifepristone has on the environment was an assessment from 1996. They claimed the survey, which was relied on by the Food and Drug Administration when it approved the medication in 2000, ‘failed to consider that human fetal remains and the drug’s active metabolites would be making their way into wastewater systems across the U.S.’

‘The American people deserve to know the negative effects caused by chemical abortion drugs,’ they wrote. 

The Republicans described that ‘Because chemical abortions are primarily self-induced and performed at home, the blood and placental tissue containing mifepristone’s active metabolites are flushed into wastewater systems along with the fetal remains of the unborn child.’

They further requested answers from Biden’s EPA, asking how the agency plans to ‘ensure the safety of our waterways and drinking water,’ what the ‘negative health effects for humans associated with exposure to mifepristone and fetal remains in drinking water’ are, and how aquatic animals might also be affected. 

‘Once received, EPA will review this letter and will respond appropriately,’ the agency told Fox News Digital. 

Mifepristone has encountered significant controversy as Republicans scrutinize the medication and what they say are lax regulations for it, while Democrats hail the drug as safe, effective and even necessary health care, while abortion access continues to be limited across the country. 

Abortion rights groups have likened various concerns over the drug and its implementation to attempts to exercise control over women’s bodily autonomy. 

‘Study after study has shown medication abortion and mifepristone to be safe and effective — with or without a health center visit. Those findings have only grown clearer in the more than two decades mifepristone has been on the U.S. market,’ Planned Parenthood Federation of America President and CEO Alexis McGill Johnson said in a statement earlier this year. 

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Could verdict in Trump criminal trial upend the presidential election?
next post
Supreme Court Justice Alito addresses flag incidents, says he won’t recuse himself in Trump, Jan. 6 cases

You may also like

Feds say railroads must re-examine train assembly amid...

April 8, 2023

Congressional leaders unveil bill to fund government, Johnson...

March 4, 2024

Hunter Biden tries to avoid in-person arraignment in...

September 19, 2023

Trump won’t wait for Senate confirmations to shake...

January 17, 2025

Oklahoma Gov. Stitt, panel see $2B budget increase...

February 18, 2023

Revelation of secret Obama-era program casts doubt on...

May 23, 2024

US frees up billions in sanctions relief to...

March 16, 2024

6-Year-Old Canadian Kid Child Suddenly After Suffering “Massive...

December 8, 2022

“I Can See Why They’re Trying To Silence...

September 16, 2022

Clooney, Hollywood line up behind Harris as celebrity...

July 23, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Wireless Logic valued at £3.5bn as founder sells minority stake to General Atlantic

      May 16, 2025
    • UK business investment surges at fastest pace in two years, defying tax hike fears

      May 16, 2025
    • NatWest nears full reprivatisation as taxpayer stake falls below 1%

      May 16, 2025
    • Gabbard says Comey should be ‘put behind bars’ after picture allegedly ‘issuing a call to assassinate’ Trump

      May 16, 2025
    • No Deposit Casino Bonus: Hidden Terms to Look Out For 

      May 16, 2025
    • RFK Jr’s HHS to end routine COVID vaccine guidance for children, pregnant women: report

      May 16, 2025

    Categories

    • Business (7,972)
    • Investing (1,964)
    • Politics (15,241)
    • Stocks (3,085)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved